DaVita Inc. Files 8-K Report
Ticker: DVA · Form: 8-K · Filed: 2024-09-05T00:00:00.000Z
Sentiment: neutral
Topics: corporate-governance, filing
TL;DR
DaVita filed an 8-K, mostly procedural stuff, no major news yet.
AI Summary
On September 5, 2024, DaVita Inc. filed an 8-K report. The filing primarily concerns amendments to its Articles of Incorporation or Bylaws, other events, and financial statements and exhibits. No specific financial figures or significant operational changes were detailed in the provided excerpt.
Why It Matters
This filing indicates routine corporate updates and potential amendments to governing documents, which could impact the company's legal structure or operational framework.
Risk Assessment
Risk Level: low — The filing appears to be routine corporate housekeeping and does not disclose any immediate material risks or significant operational changes.
Key Players & Entities
- DAVITA INC. (company) — Registrant
- 0000927066-24-000162 (other) — Accession Number
- September 5, 2024 (date) — Date of Report
- 2000 16th Street Denver, CO 80202 (location) — Principal Executive Offices
FAQ
What specific amendments were made to DaVita Inc.'s Articles of Incorporation or Bylaws?
The provided excerpt does not detail the specific amendments made to the Articles of Incorporation or Bylaws.
Were there any significant 'Other Events' reported by DaVita Inc. on September 5, 2024?
The excerpt mentions 'Other Events' as an item of information but does not specify what those events were.
What is the purpose of filing financial statements and exhibits in this 8-K?
The filing indicates that financial statements and exhibits are included, but their specific content or purpose is not detailed in the provided text.
What is DaVita Inc.'s fiscal year end?
DaVita Inc.'s fiscal year ends on December 31st.
What is the Commission File Number for DaVita Inc.?
The Commission File Number for DaVita Inc. is 001-14106.
From the Filing
0000927066-24-000162.txt : 20240905 0000927066-24-000162.hdr.sgml : 20240905 20240905171223 ACCESSION NUMBER: 0000927066-24-000162 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240905 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240905 DATE AS OF CHANGE: 20240905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 241282160 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva-20240905.htm 8-K dva-20240905 0000927066 false 12-31 0000927066 2024-09-05 2024-09-05   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (date of earliest event reported): September 5, 2024     DAVITA INC. (Exact name of registrant as specified in its charter)     DE 1-14106 51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   2000 16th Street Denver, CO 80202 (Address of principal executive offices including Zip Code)   ( 720 ) 631-2100 (Registrant’s telephone number, including area code)   Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)   ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class:   Trading symbol(s): Name of each exchange on which registered: Common Stock, $0.001 par value   DVA New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐     Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On September 5, 2024, the board of directors (the "Board") of DaVita Inc. (the "Company") adopted amended and restated bylaws of the Company (the bylaws, as so amended and restated, the “Amended and Restated Bylaws”), effective immedi